News

New guidelines to focus on mixed features in depression, bipolar

View on the News

‘Whole body’ approach to mood disorders makes sense

This more holistic way of thinking about depression is one I endorse. It makes sense to conceptualize bipolar disorder as a whole body disorder rather than a condition that is specific to the brain. The clinical implications are that we need to consider integration of care approaches that can reduce stress and inflammation generally, and minimize the complications of medical conditions seen in people with bipolar disorder. Some behavioral therapies are protective against inflammation and are recommended in the guidelines. These include attention to sleep, diet, and exercise. Social rhythm therapy is underutilized, as are other types of psychosocial approaches. Appropriate access to and use of medical care to help manage medical conditions is important, and integrated medical care that considers both body and mind may be helpful.

Martha Sajatovic, MD, is the Willard Brown Chair in Neurological Outcomes Research, and director of the Neurological Outcomes Center at the University Hospitals Case Medical Center in Cleveland. She is professor of psychiatry and of neurology at Case Western Reserve University, also in Cleveland. Dr. Sajatovic reported she has several industry relationships, including with Janssen, Merck, Ortho-McNeil, and Pfizer.


 

EXPERT ANALYSIS AT SUMMIT IN NEUROLOGY & PSYCHIATRY

References

The guidelines have been peer reviewed and will be published in the Journal of Clinical Psychiatry later this year, Dr. McIntyre said.

The meeting was held by Global Academy for Medical Education. Global Academy and this news organization are owned by the same company.

Dr. McIntyre disclosed that he has numerous industry relationships, including with AstraZeneca, Eli Lilly, Janssen Ortho, Lundbeck, Pfizer, and Shire.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Pages

Recommended Reading

Escitalopram falls short in patients with heart failure and depression
MDedge Psychiatry
Ketamine for treatment-resistant depression
MDedge Psychiatry
Attending religious services linked to lower suicide risk
MDedge Psychiatry
Maximize depression treatment efforts with measurement-based care
MDedge Psychiatry
FDA updates warning label for systemic fluoroquinolones
MDedge Psychiatry
Psychiatric disorders often impair antiretroviral adherence in perinatally HIV-infected teens
MDedge Psychiatry
Psychotropic drug use similar in cosmetic and medical dermatology patients
MDedge Psychiatry
VIDEO: A case study in diagnosing depression or demoralization after retirement
MDedge Psychiatry
Smartphone app helps decrease depression symptoms in pregnancy
MDedge Psychiatry
Antiretroviral efavirenz linked to increased suicidality
MDedge Psychiatry